[
  {
    "ts": "2025-08-07T22:44:00+00:00",
    "headline": "Dividend Watch: 3 Companies Boosting Payouts",
    "summary": "Everybody loves dividends, as they provide a passive income stream, limit drawdowns in other positions, and provide more than one way to profit from an investment.",
    "url": "https://finance.yahoo.com/news/dividend-watch-3-companies-boosting-224400011.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "9b817d7b-cd79-3129-8291-1eee4069c328",
      "content": {
        "id": "9b817d7b-cd79-3129-8291-1eee4069c328",
        "contentType": "STORY",
        "title": "Dividend Watch: 3 Companies Boosting Payouts",
        "description": "",
        "summary": "Everybody loves dividends, as they provide a passive income stream, limit drawdowns in other positions, and provide more than one way to profit from an investment.",
        "pubDate": "2025-08-07T22:44:00Z",
        "displayTime": "2025-08-07T22:44:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/3b0e1bda228a683a2176b41d58ccb62f",
          "originalWidth": 620,
          "originalHeight": 520,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/A5Rs1yVzf5Cya_wD6ifU9Q--~B/aD01MjA7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3b0e1bda228a683a2176b41d58ccb62f.cf.webp",
              "width": 620,
              "height": 520,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/H0k4Vjhbh7gw4.xj20mtFw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3b0e1bda228a683a2176b41d58ccb62f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/dividend-watch-3-companies-boosting-224400011.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/dividend-watch-3-companies-boosting-224400011.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MCK"
            },
            {
              "symbol": "CTAS"
            },
            {
              "symbol": "FIX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-07T20:01:00+00:00",
    "headline": "Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025",
    "summary": "$60.0M in 2Q25 Total Product Revenue More than 100 Patients Treated with Amtagvi® in 2Q25 Strategic Restructuring Extends Cash Runway into 4Q26 FY25 Total Product Revenue Guidance of $250M-$300M Reiterated SAN CARLOS, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today reported secon",
    "url": "https://finance.yahoo.com/news/iovance-biotherapeutics-reports-financial-results-200100771.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "dea245b7-ee1f-365e-a65b-592917481bdf",
      "content": {
        "id": "dea245b7-ee1f-365e-a65b-592917481bdf",
        "contentType": "STORY",
        "title": "Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025",
        "description": "",
        "summary": "$60.0M in 2Q25 Total Product Revenue More than 100 Patients Treated with Amtagvi® in 2Q25 Strategic Restructuring Extends Cash Runway into 4Q26 FY25 Total Product Revenue Guidance of $250M-$300M Reiterated SAN CARLOS, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today reported secon",
        "pubDate": "2025-08-07T20:01:00Z",
        "displayTime": "2025-08-07T20:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/cedc32b016b8dc2392e47b634c25fda0",
          "originalWidth": 418,
          "originalHeight": 137,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nnbHJYt2Jr1apRM.KiTLiA--~B/aD0xMzc7dz00MTg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/cedc32b016b8dc2392e47b634c25fda0.cf.webp",
              "width": 418,
              "height": 137,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/E8Snnw7QEiaPKF2FL8FMyw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/cedc32b016b8dc2392e47b634c25fda0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/iovance-biotherapeutics-reports-financial-results-200100771.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/iovance-biotherapeutics-reports-financial-results-200100771.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IOVA"
            },
            {
              "symbol": "MCK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-07T13:45:03+00:00",
    "headline": "Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick",
    "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
    "url": "https://finance.yahoo.com/news/growth-investor-1-stock-could-134503565.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "b6e93e00-d39a-31b5-90ca-082ccb4b4b8d",
      "content": {
        "id": "b6e93e00-d39a-31b5-90ca-082ccb4b4b8d",
        "contentType": "STORY",
        "title": "Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick",
        "description": "",
        "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
        "pubDate": "2025-08-07T13:45:03Z",
        "displayTime": "2025-08-07T13:45:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/d0d4ab152198da2f423d92da8a7d22ee",
          "originalWidth": 900,
          "originalHeight": 876,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/H7_MbG.UY.XzK7FHlqhSdQ--~B/aD04NzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d0d4ab152198da2f423d92da8a7d22ee.cf.webp",
              "width": 900,
              "height": 876,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9cdhr7KlQi2r1salrGcJQg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d0d4ab152198da2f423d92da8a7d22ee.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/growth-investor-1-stock-could-134503565.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/growth-investor-1-stock-could-134503565.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MCK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-07T12:22:00+00:00",
    "headline": "MCK Stock Down Despite Q1 Earnings Beat & Raised '26 EPS View",
    "summary": "McKesson beats on Q1 earnings and raises FY26 EPS view, but shares slip as gross margin narrows and spin-off plans weigh on investors' sentiment.",
    "url": "https://finance.yahoo.com/news/mck-stock-down-despite-q1-122200376.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "af8a6b09-b4e2-3e8b-9bfe-23b91791e4fe",
      "content": {
        "id": "af8a6b09-b4e2-3e8b-9bfe-23b91791e4fe",
        "contentType": "STORY",
        "title": "MCK Stock Down Despite Q1 Earnings Beat & Raised '26 EPS View",
        "description": "",
        "summary": "McKesson beats on Q1 earnings and raises FY26 EPS view, but shares slip as gross margin narrows and spin-off plans weigh on investors' sentiment.",
        "pubDate": "2025-08-07T12:22:00Z",
        "displayTime": "2025-08-07T12:22:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/863d153925c0cc5950906ad3869a2441",
          "originalWidth": 620,
          "originalHeight": 526,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QnonRcRxvBcES83yw1mIMQ--~B/aD01MjY7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/863d153925c0cc5950906ad3869a2441.cf.webp",
              "width": 620,
              "height": 526,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hpkSOn9LSx9RBAhEDv3QzQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/863d153925c0cc5950906ad3869a2441.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mck-stock-down-despite-q1-122200376.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mck-stock-down-despite-q1-122200376.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "WST"
            },
            {
              "symbol": "MCK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]